115.67 -9.04(-7.25%)09/18/2024
BioNTech SE (BNTX)
BioNTech SE (BNTX)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| How BioNTech, Up 25% Over Four Days, Is Riding Summit's Coattails To A Recovery | 09/17 12:25 | investors.com |
| BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024 | 09/17 06:45 | globenewswire.com |
| BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar? | 09/13 10:36 | zacks.com |
| BioNTech's Low Valuation, Many Shots On Goal Make It A Buy | 09/11 07:20 | seekingalpha.com |
| BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024 | 09/05 07:15 | globenewswire.com |
| BioNTech BNT116 Lung Cancer mRNA Vaccine Clinical Trials Initiated | 08/25 13:30 | globenewswire.com |
| Genmab: Strong H1 2024 Performance, Partner BioNTech Gives Up On Acasunlimab | 08/23 11:55 | seekingalpha.com |
| Lung cancer patient is first in UK to receive experimental vaccine | 08/22 19:29 | news.sky.com |
| Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine | 08/22 14:15 | globenewswire.com |